SHL Overzicht aandelen
Siemens Healthineers AG ontwikkelt, produceert en verkoopt via zijn dochterondernemingen een reeks diagnostische en therapeutische producten en diensten aan zorgverleners over de hele wereld.
Sneeuwvlok Score | |
---|---|
Waardering | 5/6 |
Toekomstige groei | 2/6 |
Prestaties in het verleden | 5/6 |
Financiële gezondheid | 2/6 |
Dividenden | 3/6 |
Beloningen
Risicoanalyse
Siemens Healthineers AG Concurrenten
Prijsgeschiedenis en prestaties
Historische aandelenkoersen | |
---|---|
Huidige aandelenkoers | €48.34 |
52 Week Hoogtepunt | €58.14 |
52 Week Laag | €46.87 |
Bèta | 0.70 |
11 maand verandering | -6.72% |
3 maanden verandering | -2.19% |
1 Jaar Verandering | 0.75% |
33 jaar verandering | -19.73% |
5 jaar verandering | 14.55% |
Verandering sinds IPO | 60.07% |
Recent nieuws en updates
Earnings Tell The Story For Siemens Healthineers AG (ETR:SHL)
Oct 21Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Jul 22Investors Still Waiting For A Pull Back In Siemens Healthineers AG (ETR:SHL)
Jun 16Recent updates
Earnings Tell The Story For Siemens Healthineers AG (ETR:SHL)
Oct 21Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Jul 22Investors Still Waiting For A Pull Back In Siemens Healthineers AG (ETR:SHL)
Jun 16Is There An Opportunity With Siemens Healthineers AG's (ETR:SHL) 49% Undervaluation?
May 06Siemens Healthineers (ETR:SHL) Takes On Some Risk With Its Use Of Debt
Mar 29Siemens Healthineers AG's (ETR:SHL) P/E Still Appears To Be Reasonable
Feb 22The Siemens Healthineers AG (ETR:SHL) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Feb 04Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Dec 18Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Aug 24Siemens Healthineers AG's (ETR:SHL) Intrinsic Value Is Potentially 26% Above Its Share Price
Jun 08Calculating The Fair Value Of Siemens Healthineers AG (ETR:SHL)
Mar 03Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95
Feb 13It's Unlikely That Siemens Healthineers AG's (ETR:SHL) CEO Will See A Huge Pay Rise This Year
Feb 09Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Jan 27Siemens Healthineers' (ETR:SHL) Upcoming Dividend Will Be Larger Than Last Year's
Jan 09Siemens Healthineers (ETR:SHL) Has Announced That It Will Be Increasing Its Dividend To €0.95
Dec 18Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95
Nov 17An Intrinsic Calculation For Siemens Healthineers AG (ETR:SHL) Suggests It's 33% Undervalued
Nov 01Is Now The Time To Put Siemens Healthineers (ETR:SHL) On Your Watchlist?
Oct 01Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Aug 05Siemens Healthineers (ETR:SHL) Ticks All The Boxes When It Comes To Earnings Growth
Jun 24Does Siemens Healthineers (ETR:SHL) Have A Healthy Balance Sheet?
Apr 18We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Siemens Healthineers AG's (ETR:SHL) CEO For Now
Feb 08Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?
Jan 16I Built A List Of Growing Companies And Siemens Healthineers (ETR:SHL) Made The Cut
Dec 05Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Sep 06Siemens Healthineers AG (ETR:SHL) Shares Could Be 40% Below Their Intrinsic Value Estimate
Jul 26We Think Siemens Healthineers (ETR:SHL) Can Stay On Top Of Its Debt
Jun 01A Look At The Intrinsic Value Of Siemens Healthineers AG (ETR:SHL)
Apr 20Siemens Healthineers AG's (ETR:SHL) Stock Is Going Strong: Have Financials A Role To Play?
Mar 12Key Things To Consider Before Buying Siemens Healthineers AG (ETR:SHL) For Its Dividend
Feb 24Four Days Left To Buy Siemens Healthineers AG (ETR:SHL) Before The Ex-Dividend Date
Feb 09How Much Of Siemens Healthineers AG (ETR:SHL) Do Institutions Own?
Jan 29Estimating The Fair Value Of Siemens Healthineers AG (ETR:SHL)
Jan 14Should You Use Siemens Healthineers's (ETR:SHL) Statutory Earnings To Analyse It?
Dec 30Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?
Dec 15Would Shareholders Who Purchased Siemens Healthineers' (ETR:SHL) Stock Year Be Happy With The Share price Today?
Nov 30Rendement voor aandeelhouders
SHL | DE Medical Equipment | DE Markt | |
---|---|---|---|
7D | -5.8% | -6.0% | -1.8% |
1Y | 0.8% | -3.5% | 13.2% |
Rendement versus industrie: SHL overtrof de German Medical Equipment industrie, die het afgelopen jaar een rendement -3.5 % opleverde.
Rendement versus markt: SHL presteerde slechter dan German Market, dat het afgelopen jaar een rendement van 13.2 % opleverde.
Prijsvolatiliteit
SHL volatility | |
---|---|
SHL Average Weekly Movement | 3.0% |
Medical Equipment Industry Average Movement | 5.3% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 11.5% |
10% least volatile stocks in DE Market | 2.4% |
Stabiele aandelenkoers: SHL heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van SHL is het afgelopen jaar stabiel geweest.
Over het bedrijf
Opgericht | Werknemers | CEO | Website |
---|---|---|---|
n/a | 71,800 | Bernd Montag | www.siemens-healthineers.com |
Siemens Healthineers AG ontwikkelt, produceert en verkoopt via haar dochterondernemingen een reeks diagnostische en therapeutische producten en diensten aan zorgverleners wereldwijd. Het bedrijf is actief in vier segmenten: Imaging, Diagnostics, Varian en Advanced Therapies. Het segment Imaging levert magnetische resonantiebeeldvorming, computertomografie, röntgensystemen, moleculaire beeldvorming en ultrasone systemen.
Siemens Healthineers AG Samenvatting
SHL fundamentele statistieken | |
---|---|
Marktkapitalisatie | €53.94b |
Inkomsten(TTM) | €1.86b |
Inkomsten(TTM) | €22.09b |
29.0x
Koers/Winstverhouding2.4x
P/S-verhoudingIs SHL overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
SHL resultatenrekening (TTM) | |
---|---|
Inkomsten | €22.09b |
Kosten van inkomsten | €13.74b |
Brutowinst | €8.35b |
Overige uitgaven | €6.49b |
Inkomsten | €1.86b |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
Nov 06, 2024
Winst per aandeel (EPS) | 1.67 |
Brutomarge | 37.81% |
Nettowinstmarge | 8.43% |
Schuld/Eigen Vermogen Verhouding | 92.2% |
Hoe presteerde SHL op de lange termijn?
Bekijk historische prestaties en vergelijking